D-cycloserine augmentation for behavioral therapy

American Journal of Psychiatry

Volumn 165, Issue 8, 2008, Pages 1050-

  Shim, Seong S ^a   Hammonds, Michael D ^a   Vrabel, Matthew M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; DEXTRO SERINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; BEHAVIOR THERAPY; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LEARNING; LETTER; LOW DRUG DOSE; MEMORY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION;

ANTIMETABOLITES; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOSERINE; GLYCINE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 48949090094     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08030455     Document Type: Letter

References (4)

1. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL: Augmentation of behavioral therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008; 165:335-341
2. Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlya M, MCCabe J, Peterson J, Foa EB: D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 2007; 62:835-838
3. Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK: D-Cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2007; 22:230-237
4. Shim SS, Hammonds MD, Kee BS: Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry Clin Neurosci 2007; 258:16-27